4//SEC Filing
Wang Julia Aijun 4
Accession 0001651308-23-000091
CIK 0001651308other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 6:51 PM ET
Size
10.2 KB
Accession
0001651308-23-000091
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Wang Julia Aijun
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2023-06-15+107,770→ 342,303 total - Sale
American Depositary Shares
2023-06-20$192.54/sh−190$36,583→ 0 total - Award
Share Option (Right to Buy)
2023-06-15+409,058→ 409,058 totalExercise: $16.41Exp: 2033-06-14→ Ordinary Shares (409,058 underlying)
Footnotes (6)
- [F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
- [F2]Each American Depositary Share represents 13 Ordinary Shares.
- [F3]The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.50 to $192.58, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- [F5]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- [F6]These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events following a change in control.
Documents
Issuer
BeiGene, Ltd.
CIK 0001651308
Entity typeother
Related Parties
1- filerCIK 0001860279
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 6:51 PM ET
- Size
- 10.2 KB